Levosimendan for Injection(Brilliant Pharma)

注射用左西孟旦（海南倍特药业）

Report date: 2025/08/26 16:43:02

Base Information

Drug NameLevosimendan for Injection(Brilliant Pharma)
Drug Alias NameDaxim左西查坦Oral levosimendan - Orion左西咪旦levosimendanum +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonistsTroponin, cardiac muscle modulatorsVoltage-gated potassium channel agonists +[4] 
TargetsPotassium channelVoltage-gated potassium channelPhosphodiesterase 3 +[4] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBrilliant Pharmaceutical Co Ltd Hainan
China Registration ClassN/A

Develop Information

Active CompaniesBrilliant Pharmaceutical Co Ltd Hainan
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG